Louvain Drug Research Institute, Clinical Pharmacy Research Group, Université catholique de Louvain, Brussels, Belgium; Geriatric Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute of Health and Society, Université catholique de Louvain, Brussels, Belgium.
Louvain Drug Research Institute, Clinical Pharmacy Research Group, Université catholique de Louvain, Brussels, Belgium.
Int J Med Inform. 2019 Jun;126:138-146. doi: 10.1016/j.ijmedinf.2019.03.013. Epub 2019 Apr 6.
Medication discrepancies, which are a threat to patient safety, can be reduced by medication reconciliation (MedRec). MedRec is a complex process that can be supported by the use of information technology and patient engagement. Therefore, the SEAMPAT project aims to develop a MedRec IT platform based on two applications. The application for the professionals is called: the "MedRec app".
In the present study, we aimed to describe the development and usability testing of the MedRec app, reporting results of a three iterations user-centered usability evaluation.
We used a three phase iterative user-centered study spread over 16 months. At each phase, the usability evaluation included several methods (observations, questionnaires, and follow-up discussions with participants) to collect quantitative and qualitative data in order to improve the current prototype and evolve to the next prototype.
In total, 48 healthcare professionals (25 general practitioners and 23 hospital clinicians) participated to the MedRec app evaluation. There were 14, 32 and 5 participants for phases 1, 2 and 3 respectively. At each phase, many design modifications were done to strengthen usability. Concerning usability, participants considered the prototypes as an acceptable interface with a median System Usability Score of 73 at phase 2 and 75 at phase 3. Participants emphasized the need for improvements concerning workflow integration, usefulness and interoperability.
The MedRec app was perceived as being useful, usable and satisfying. However, further improvements are required in several usability aspects. Our study demonstrates the importance of conducting usability assessments before investing time and resources in a large study evaluating the effect of an eMedRec approach on clinical outcomes. Our findings may also increase the chances of acceptability and sustained use over time by clinicians.
药物差异会威胁患者安全,可以通过药物重整(MedRec)来减少。MedRec 是一个复杂的过程,可以通过信息技术和患者参与来支持。因此,SEAMPAT 项目旨在开发一个基于两个应用程序的 MedRec IT 平台。专业人员使用的应用程序称为:“MedRec 应用程序”。
在本研究中,我们旨在描述 MedRec 应用程序的开发和可用性测试,报告三轮以用户为中心的可用性评估的结果。
我们使用了一个三阶段迭代的以用户为中心的研究,历时 16 个月。在每个阶段,可用性评估包括几种方法(观察、问卷调查和与参与者的后续讨论),以收集定量和定性数据,从而改进当前原型并演进到下一个原型。
共有 48 名医疗保健专业人员(25 名全科医生和 23 名医院临床医生)参与了 MedRec 应用程序的评估。各阶段的参与者分别为 14、32 和 5 人。在每个阶段,都对设计进行了多次修改,以增强可用性。关于可用性,参与者认为原型是一个可以接受的界面,第二阶段的系统可用性得分中位数为 73,第三阶段为 75。参与者强调需要改进工作流程集成、有用性和互操作性。
MedRec 应用程序被认为是有用的、可用的和令人满意的。然而,在几个可用性方面还需要进一步改进。我们的研究表明,在投资时间和资源进行评估电子药物重整方法对临床结果的影响之前,进行可用性评估非常重要。我们的研究结果还可能增加临床医生在未来接受和持续使用的可能性。